Complete Filing Data
Enliven Therapeutics, Inc. reported Stockholders Equity of $459.60 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Enliven Therapeutics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Income Loss | -$103.7M | -$89.0M | -$71.6M | -$37.7M | -$51.4M | -$41.4M | -$23.5M |
| Research And Development Expense | $85.9M | $80.8M | $64.6M | $31.0M | $38.4M | $32.2M | $19.0M |
| Operating Income Loss | -$119.7M | -$104.6M | -$83.5M | -$38.8M | -$51.4M | -$41.7M | -$24.1M |
| Operating Expenses | $119.7M | $104.6M | $83.5M | $38.8M | $51.4M | $41.7M | $24.1M |
| General And Administrative Expense | $33.8M | $23.8M | $19.0M | $7.8M | $13.0M | $9.5M | $5.1M |
| Nonoperating Income Expense | $16.0M | $15.5M | $11.9M | $1.1M | $58.0K | $338.0K | $653.0K |
| Interest Income Expense Nonoperating Net | $16.0M | $14.9M | $12.0M | $1.1M | $233.0K | $483.0K | $578.0K |
| Comprehensive Income Net Of Tax | -$103.4M | -$89.1M | -$71.4M | -$37.7M | -$51.4M | -$41.4M | -$23.4M |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $279.0K | -$86.0K | $141.0K | $0.00 | -$20.0K | -$28.0K | $32.0K |
| Other Nonoperating Income Expense | -$49.0K | -$2.0K | -$22.0K | $0.00 | -$175.0K | -$145.0K | $75.0K |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -$20.0K | -$28.0K | $32.0K | ||||
| Net Income Loss Attributable To Common Stockholders Basic And Diluted | $1.5M | -$51.4M | -$49.2M | -$23.5M | |||
| Other Comprehensive Income Loss Net Of Tax | $279.0K | -$86.0K | $141.0K | ||||
| Income Tax Expense Benefit | $0.00 | $232.0K | $0.00 | $88.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$20.1M | -$25.3M | -$28.5M | -$23.2M | -$20.0M | -$22.7M | -$20.8M | -$16.7M | -$14.7M | -$10.6M | -$8.9M | -$8.7M | -$13.6M | -$13.2M | -$10.3M | -$12.4M | -$10.2M | -$7.2M | -$6.6M | -$5.4M | -$4.2M |
| Research And Development Expense | $18.2M | $21.5M | $24.9M | $21.3M | $18.8M | $20.0M | $19.6M | $15.2M | $11.9M | $7.8M | $7.9M | $7.1M | $10.4M | $10.1M | $7.1M | $9.5M | $7.9M | $5.8M | $5.1M | $4.4M | $3.6M |
| Operating Income Loss | -$25.1M | -$28.6M | -$31.7M | -$27.1M | -$24.6M | -$26.0M | -$24.2M | -$20.1M | -$16.4M | -$10.9M | -$9.0M | -$8.7M | -$13.7M | -$13.2M | -$10.3M | -$12.5M | -$10.3M | -$7.4M | -$6.9M | -$5.6M | -$4.2M |
| Operating Expenses | $25.1M | $28.6M | $31.7M | $27.1M | $24.6M | $26.0M | $24.2M | $20.1M | $16.4M | $10.9M | $9.0M | $8.7M | $13.7M | $13.2M | $10.3M | $12.5M | $10.3M | $7.4M | $6.9M | $5.6M | $4.2M |
| General And Administrative Expense | $6.9M | $7.1M | $6.8M | $5.8M | $5.8M | $6.0M | $4.6M | $5.0M | $4.5M | $3.1M | $1.1M | $1.6M | $3.3M | $3.1M | $3.2M | $3.0M | $2.4M | $1.6M | $1.7M | $1.2M | $634.0K |
| Nonoperating Income Expense | $4.9M | $3.2M | $3.1M | $3.9M | $4.7M | $3.2M | $3.5M | $3.4M | $1.7M | $380.0K | $127.0K | $9.0K | $12.0K | $8.0K | $23.0K | $71.0K | $98.0K | $137.0K | $260.0K | $160.0K | |
| Interest Income Expense Nonoperating Net | $4.9M | $3.3M | $3.2M | $3.8M | $4.1M | $3.3M | $3.5M | $3.4M | $1.7M | $380.0K | $127.0K | $9.0K | $30.0K | $48.0K | $83.0K | $126.0K | $110.0K | $132.0K | $254.0K | $160.0K | |
| Comprehensive Income Net Of Tax | -$19.8M | -$25.5M | -$28.6M | -$22.8M | -$20.0M | -$22.9M | -$20.8M | -$16.8M | -$14.7M | -$10.6M | -$8.9M | -$14.7M | -$13.6M | -$13.2M | -$10.3M | -$12.4M | -$10.1M | -$7.3M | -$6.6M | -$5.4M | -$4.2M |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $398.0K | -$161.0K | -$71.0K | $381.0K | -$86.0K | -$194.0K | -$36.0K | -$111.0K | $0.00 | $0.00 | $0.00 | -$35.0K | -$2.0K | -$1.0K | -$3.0K | -$24.0K | $64.0K | -$48.0K | $30.0K | ||
| Other Nonoperating Income Expense | $0.00 | -$2.0K | -$47.0K | $0.00 | -$1.0K | -$1.0K | -$13.0K | $0.00 | $0.00 | $0.00 | -$38.0K | -$56.0K | -$18.0K | -$40.0K | -$60.0K | -$55.0K | -$12.0K | $5.0K | $6.0K | ||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $31.0K | $16.0K | -$35.0K | -$2.0K | -$1.0K | -$3.0K | -$24.0K | $64.0K | -$48.0K | $30.0K | |||||||||||
| Net Income Loss Attributable To Common Stockholders Basic And Diluted | -$4.6M | -$11.4M | -$14.6M | -$13.6M | -$13.2M | -$10.3M | -$12.4M | -$10.2M | -$15.1M | -$6.6M | -$5.4M | -$4.2M | |||||||||
| Other Comprehensive Income Loss Net Of Tax | $398.0K | -$161.0K | -$71.0K | $381.0K | -$86.0K | -$194.0K | -$36.0K | -$111.0K | |||||||||||||
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 | $232.0K | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $459.6M | $309.8M | $245.9M | -$76.8M | -$42.9M | $84.4M | -$48.8M | -$26.3M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $98.9M | $124.2M | $100.2M | $75.6M | $110.1M | $47.8M | $5.0M | $7.4M |
| Cash And Cash Equivalents At Carrying Value | $98.9M | $124.1M | $100.1M | $75.5M | $48.3M | $47.7M | $4.9M | |
| Common Stock Value | $59.0K | $49.0K | $41.0K | $1.0K | $27.0K | $18.0K | $1.0K | |
| Retained Earnings Accumulated Deficit | -$347.2M | -$243.5M | -$154.4M | -$82.9M | -$147.5M | -$96.1M | -$54.8M | |
| Prepaid Expense And Other Assets Current | $12.3M | $4.6M | $2.9M | $2.2M | $2.4M | $2.2M | $1.7M | |
| Liabilities Current | $16.6M | $15.9M | $25.9M | $9.7M | $7.2M | $6.2M | $4.2M | |
| Liabilities And Stockholders Equity | $476.2M | $325.8M | $271.9M | $83.3M | $93.6M | $90.8M | $33.3M | |
| Liabilities | $16.6M | $15.9M | $26.0M | $10.4M | $7.6M | $6.4M | $4.4M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$25.3M | $24.0M | $24.6M | -$34.5M | $698.0K | $42.8M | -$2.4M | |
| Assets Current | $474.9M | $318.1M | $266.2M | $77.8M | $92.7M | $90.4M | $30.6M | |
| Assets | $476.2M | $325.8M | $271.9M | $83.3M | $93.6M | $90.8M | $33.3M | |
| Accrued Expenses And Other Current Liabilities | $14.4M | $14.6M | $15.4M | $6.3M | $4.6M | $4.3M | $2.5M | |
| Accounts Payable Current | $2.2M | $1.3M | $532.0K | $3.4M | $2.4M | $2.0M | $1.7M | |
| Property Plant And Equipment Net | $34.0K | $458.0K | $742.0K | $890.0K | $250.0K | $349.0K | $442.0K | |
| Restricted Cash | $0.00 | $54.0K | $54.0K | $54.0K | $175.0K | $88.0K | $88.0K | |
| Other Assets Noncurrent | $656.0K | $7.2M | $4.1M | $0.00 | $175.0K | $88.0K | $2.2M | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | $334.0K | $55.0K | $141.0K | $0.00 | -$16.0K | $4.0K | $32.0K | |
| Accretion Amortization Of Discounts And Premiums Investments | $227.0K | -$424.0K | $4.6M | $0.00 | -$155.0K | -$122.0K | $19.0K | |
| Operating Lease Right Of Use Asset | $383.0K | $0.00 | $320.0K | $626.0K | $525.0K | |||
| Other Liabilities Noncurrent | $67.0K | $659.0K | ||||||
| Non Cash Lease Expense | $353.0K | $320.0K | $306.0K | $0.00 | ||||
| Available For Sale Securities Debt Securities Current | $42.0M | $40.5M | $24.0M | |||||
| Marketable Securities Current | $363.7M | $189.3M | $153.0M | $0.00 | ||||
| Deferred Offering Costs Non Current | $217.0K | $0.00 | $563.0K | $4.0M | ||||
| Unrealized Gain Loss On Investments | -$20.0K | -$28.0K | ||||||
| Changes In Fair Value Of Contingent Value Right Liability | $0.00 | $873.0K | $0.00 | |||||
| Restricted Cash Current | $0.00 | $54.0K | $54.0K | $0.00 | ||||
| Receivables From Stock Option Exercises Included In Prepaid Expenses And Other Current Assets | $0.00 | $76.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $476.1M | $488.5M | $288.3M | $288.4M | $304.9M | $317.7M | $261.7M | $279.0M | $291.4M | -$68.1M | -$58.7M | -$50.6M | $99.4M | $65.0M | $75.6M | $94.7M | $106.3M | $105.2M | -$41.9M | -$35.6M | -$30.4M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $101.7M | $119.4M | $101.7M | $100.7M | $96.9M | $149.2M | $73.9M | $125.8M | $292.2M | $86.2M | $92.5M | $99.9M | $75.5M | $48.2M | $53.5M | $34.2M | $54.7M | $86.8M | $17.2M | $45.3M | $48.9M | |
| Cash And Cash Equivalents At Carrying Value | $101.7M | $119.4M | $101.7M | $100.6M | $96.9M | $149.2M | $73.8M | $125.7M | $292.1M | $86.2M | $92.5M | $99.9M | $75.3M | $48.0M | $53.4M | $34.2M | $54.7M | $86.7M | $17.1M | $45.2M | $48.9M | |
| Common Stock Value | $59.0K | $59.0K | $49.0K | $47.0K | $47.0K | $47.0K | $41.0K | $41.0K | $41.0K | $27.0K | $27.0K | $27.0K | $27.0K | $19.0K | $18.0K | $18.0K | $18.0K | $17.0K | ||||
| Retained Earnings Accumulated Deficit | -$317.5M | -$297.4M | -$272.0M | -$220.3M | -$197.1M | -$177.2M | -$135.1M | -$114.3M | -$97.6M | -$178.2M | -$173.6M | -$162.1M | -$133.2M | -$119.5M | -$106.4M | -$84.6M | -$72.2M | -$62.0M | ||||
| Prepaid Expense And Other Assets Current | $5.1M | $5.1M | $4.8M | $5.1M | $5.7M | $6.6M | $5.1M | $5.3M | $5.9M | $2.8M | $3.9M | $5.6M | $3.2M | $4.6M | $4.8M | $3.6M | $4.3M | $3.9M | ||||
| Liabilities Current | $14.7M | $15.2M | $14.0M | $17.0M | $22.1M | $25.0M | $12.1M | $9.1M | $10.9M | $1.8M | $3.3M | $7.2M | $7.2M | $7.0M | $5.5M | $5.3M | $4.8M | $4.9M | ||||
| Liabilities And Stockholders Equity | $490.9M | $503.9M | $302.6M | $305.4M | $327.0M | $342.8M | $274.0M | $288.5M | $302.9M | $59.1M | $64.7M | $81.6M | $107.0M | $72.5M | $81.7M | $100.2M | $111.3M | $110.3M | ||||
| Liabilities | $14.8M | $15.4M | $14.3M | $17.0M | $22.1M | $25.1M | $12.3M | $9.5M | $11.5M | $1.8M | $3.3M | $9.2M | $7.7M | $7.5M | $6.1M | $5.5M | $5.0M | $5.1M | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$22.5M | $49.0M | $216.6M | -$10.1M | $5.7M | $81.8M | $41.5M | |||||||||||||||
| Assets Current | $482.7M | $495.6M | $294.3M | $297.0M | $318.1M | $337.2M | $268.6M | $283.2M | $298.0M | $59.1M | $64.3M | $78.5M | $106.0M | $71.4M | $80.4M | $99.7M | $110.6M | $109.8M | ||||
| Assets | $490.9M | $503.9M | $302.6M | $305.4M | $327.0M | $342.8M | $274.0M | $288.5M | $302.9M | $59.1M | $64.7M | $81.6M | $107.0M | $72.5M | $81.7M | $100.2M | $111.3M | $110.3M | ||||
| Accrued Expenses And Other Current Liabilities | $13.2M | $12.9M | $12.4M | $16.0M | $11.8M | $12.3M | $10.6M | $6.3M | $5.1M | $1.1M | $1.7M | $4.8M | $4.5M | $4.1M | $2.2M | $3.4M | $3.2M | $2.6M | ||||
| Accounts Payable Current | $1.4M | $2.4M | $1.6M | $1.0M | $1.1M | $2.7M | $1.5M | $2.8M | $5.9M | $767.0K | $1.1M | $1.9M | $2.5M | $2.6M | $3.0M | $1.9M | $1.7M | $2.3M | ||||
| Property Plant And Equipment Net | $399.0K | $462.0K | $404.0K | $549.0K | $630.0K | $683.0K | $806.0K | $867.0K | $853.0K | $105.0K | $588.0K | $275.0K | $299.0K | $324.0K | $376.0K | $400.0K | $418.0K | |||||
| Restricted Cash | $0.00 | $0.00 | $0.00 | $54.0K | $54.0K | $54.0K | $54.0K | $54.0K | $54.0K | $54.0K | $54.0K | $54.0K | $175.0K | $175.0K | $88.0K | $88.0K | $88.0K | $88.0K | $88.0K | $88.0K | ||
| Other Assets Noncurrent | $7.1M | $7.2M | $7.2M | $7.2M | $7.6M | $4.1M | $3.6M | $3.4M | $3.4M | $175.0K | $175.0K | $175.0K | $175.0K | $308.0K | $88.0K | $324.0K | $88.0K | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $221.0K | -$177.0K | -$16.0K | $242.0K | -$139.0K | -$53.0K | -$147.0K | -$111.0K | -$4.0K | -$35.0K | -$51.0K | -$2.0K | $1.0K | $24.0K | $48.0K | -$16.0K | ||||||
| Accretion Amortization Of Discounts And Premiums Investments | $45.0K | $661.0K | $0.00 | -$48.0K | -$55.0K | -$5.0K | ||||||||||||||||
| Operating Lease Right Of Use Asset | $475.0K | $564.0K | $651.0K | $81.0K | $161.0K | $241.0K | $398.0K | $475.0K | $551.0K | $130.0K | $2.3M | $580.0K | $637.0K | $694.0K | ||||||||
| Other Liabilities Noncurrent | $103.0K | $204.0K | $302.0K | $0.00 | $0.00 | $6.0K | $34.0K | $214.0K | $360.0K | $508.0K | ||||||||||||
| Non Cash Lease Expense | $85.0K | $79.0K | $0.00 | |||||||||||||||||||
| Available For Sale Securities Debt Securities Current | $6.8M | $29.9M | $36.4M | $27.5M | $18.7M | $22.2M | $61.9M | $51.6M | $19.1M | |||||||||||||
| Marketable Securities Current | $375.8M | $371.1M | $187.9M | $191.2M | $215.5M | $171.3M | $189.6M | $152.2M | ||||||||||||||
| Deferred Offering Costs Non Current | $217.0K | $563.0K | $563.0K | $563.0K | $563.0K | $524.0K | ||||||||||||||||
| Unrealized Gain Loss On Investments | -$35.0K | -$2.0K | -$48.0K | |||||||||||||||||||
| Changes In Fair Value Of Contingent Value Right Liability | $0.00 | $0.00 | $73.0K | $800.0K | $0.00 | $0.00 | ||||||||||||||||
| Restricted Cash Current | $0.00 | $0.00 | $0.00 | $54.0K | $54.0K | $54.0K | ||||||||||||||||
| Receivables From Stock Option Exercises Included In Prepaid Expenses And Other Current Assets | $0.00 | $50.0K | $0.00 |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Share Based Compensation | $34.0M | $20.2M | $12.9M | $3.2M | $3.8M | $2.2M | $899.0K |
| Net Cash Provided By Used In Operating Activities | -$70.3M | -$73.2M | -$61.3M | -$32.1M | -$46.8M | -$37.4M | -$21.9M |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$496.0K | -$248.0K | $7.7M | $1.6M | $393.0K | $1.7M | $1.3M |
| Increase Decrease In Accounts Payable | $817.0K | $810.0K | -$2.3M | $411.0K | $389.0K | $313.0K | $750.0K |
| Payments To Acquire Productive Assets | $158.0K | $44.0K | $149.0K | $612.0K | $12.0K | $18.0K | $140.0K |
| Net Cash Provided By Used In Investing Activities | -$173.8M | -$36.0M | -$148.4M | -$612.0K | -$1.6M | -$16.7M | -$24.1M |
| Increase Decrease In Prepaid Expenses Other | $1.1M | $4.8M | $3.7M | $1.6M | $235.0K | $465.0K | $1.4M |
| Net Cash Provided By Used In Financing Activities | $218.9M | $133.2M | $234.3M | -$1.8M | $49.1M | $96.9M | $43.6M |
| Proceeds From Stock Options Exercised | $2.3M | $3.6M | $399.0K | $591.0K | $860.0K | $1.0M | |
| Payments To Acquire Marketable Securities | $446.8M | $350.7M | $268.3M | $0.00 | |||
| Proceeds From Sale Maturity And Collection Of Shortterm Investments | $41.9M | $45.9M | $47.5M | ||||
| Proceeds From Sale And Maturity Of Marketable Securities | $272.9M | $313.9M | $120.0M | $0.00 | |||
| Payments Of Stock Issuance Costs | $5.0M | $1.7M | $2.0M | ||||
| Increase Decrease In Operating Lease Liability | -$337.0K | -$335.0K | -$310.0K | $4.0K | |||
| Proceeds From Issuance Of Common Stock | $0.00 | $161.4M | $0.00 | ||||
| Proceeds From Issuance Of Common Stock And Pre Funded Warrants In The Private Placement Net Of Issuance Costs | $0.00 | $89.7M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q2 2025 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q2 2021 | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $6.8M | $4.5M | $2.3M | $654.0K | $947.0K | $360.0K | $95.0K | ||
| Net Cash Provided By Used In Operating Activities | -$24.1M | -$23.4M | -$20.8M | -$10.4M | -$13.0M | -$9.5M | -$2.4M | ||
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$2.5M | -$3.1M | -$2.9M | -$286.0K | -$2.2M | -$643.0K | $600.0K | ||
| Increase Decrease In Accounts Payable | $220.0K | $2.2M | $492.0K | -$1.6M | $1.0M | $179.0K | $931.0K | ||
| Payments To Acquire Productive Assets | $20.0K | $20.0K | $31.0K | $194.0K | $12.0K | $15.0K | |||
| Net Cash Provided By Used In Investing Activities | $1.4M | -$17.9M | -$31.0K | -$194.0K | $18.3M | $4.8M | |||
| Increase Decrease In Prepaid Expenses Other | $152.0K | $3.6M | $6.1M | $542.0K | $2.6M | $2.2M | -$161.0K | ||
| Net Cash Provided By Used In Financing Activities | $234.0K | $90.3M | $237.4M | $409.0K | $460.0K | $86.6M | $43.9M | ||
| Proceeds From Stock Options Exercised | $234.0K | $270.0K | $140.0K | $573.0K | $472.0K | ||||
| Payments To Acquire Marketable Securities | $59.2M | $56.8M | $0.00 | ||||||
| Proceeds From Sale Maturity And Collection Of Shortterm Investments | $5.5M | $22.0M | $4.8M | ||||||
| Proceeds From Sale And Maturity Of Marketable Securities | $60.7M | $38.9M | $0.00 | ||||||
| Payments Of Stock Issuance Costs | $13.9M | $170.0K | $5.0M | $357.0K | $12.0K | ||||
| Increase Decrease In Operating Lease Liability | -$69.0K | -$83.0K | -$1.0K | ||||||
| Proceeds From Issuance Of Common Stock | $0.00 | $162.9M | |||||||
| Proceeds From Issuance Of Common Stock And Pre Funded Warrants In The Private Placement Net Of Issuance Costs | $0.00 | $90.0M | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.83 | -$1.89 | -$2.01 | -$12.05 | -$2.37 | -$3.53 | -$33.40 |
| Common Stock Shares Authorized | 100.0M | 100.0M | 100.0M | 26.3M | 200.0M | 200.0M | 100.0M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Outstanding | 59.4M | 48.9M | 41.3M | 3.6M | 26.3M | 17.5M | 702.5K |
| Common Stock Shares Issued | 59.4M | 48.9M | 41.3M | 3.6M | 26.3M | 17.5M | 702.5K |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 0.00 | 10.0M | 10.0M | 0.00 |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Weighted Average Number Of Shares Outstanding Basic | 56.7M | 47.1M | 35.5M | 3.1M | 21.7M | ||
| Weighted Average Number Of Diluted Shares Outstanding | 56.7M | 47.1M | 35.5M | 3.1M | 21.7M | ||
| Earnings Per Share Basic | $-1.83 | $-1.89 | $-2.01 | $-12.05 | $-2.37 | ||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 21.7M | 13.9M | 702.5K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.32 | -$0.49 | -$0.57 | -$0.48 | -$0.41 | -$0.54 | -$0.51 | -$0.41 | -$0.80 | -$3.27 | -$2.86 | -$3.01 | -$0.74 | -$0.74 | -$0.58 | -$0.72 | -$0.59 | -$4.31 | -$9.43 | -$7.68 | -$5.97 | |
| Common Stock Shares Authorized | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | |||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Common Stock Shares Outstanding | 59.3M | 59.2M | 49.0M | 47.3M | 47.2M | 46.8M | 41.2M | 41.2M | 41.1M | 26.3M | 26.3M | 26.3M | 26.3M | 17.9M | 17.6M | 17.4M | 17.3M | 16.6M | ||||
| Common Stock Shares Issued | 59.3M | 59.2M | 49.0M | 47.3M | 47.2M | 46.8M | 41.2M | 41.2M | 41.1M | 26.3M | 26.3M | 26.3M | 26.3M | 17.9M | 17.6M | 17.4M | 17.3M | 16.6M | ||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | ||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Weighted Average Number Of Shares Outstanding Basic | 62.1M | 52.1M | 50.1M | 48.3M | 48.1M | 42.0M | 41.0M | 41.0M | 41.0M | 3.2M | 3.1M | 2.9M | 24.9M | 17.7M | ||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 62.1M | 52.1M | 50.1M | 48.3M | 48.1M | 42.0M | 41.0M | 41.0M | 41.0M | 3.2M | 3.1M | 2.9M | 17.7M | 17.7M | ||||||||
| Earnings Per Share Basic | $-0.32 | $-0.49 | $-0.57 | $-0.48 | $-0.41 | $-0.54 | $-0.51 | $-0.41 | $-0.80 | $-3.27 | $-2.86 | $-3.01 | $-0.55 | $-0.74 | ||||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 26.3M | 24.9M | 17.7M | 17.6M | 17.3M | 17.2M | 3.5M | 702.5K | 702.5K | 702.5K |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $34.0M | $20.2M | $12.9M | $3.2M | $3.8M | $2.2M | $899.0K |
| Stock Issued During Period Value Stock Options Exercised | $2.3M | $3.6M | $475.0K | $246.0K | |||
| Additional Paid In Capital | $806.4M | $553.2M | $400.2M | $6.0M | $233.5M | $180.5M | $5.9M |
| Depreciation | $263.0K | $317.0K | $297.0K | $215.0K | $99.0K | $97.0K | $33.0K |
| Vesting Of Restricted Stock And Stock Options | $67.0K | $273.0K | $295.0K | $287.0K | |||
| Stock Issued During Period Value New Issues | $159.5M | $76.5M | |||||
| Stock Issued During Period Value Conversion Of Convertible Securities | $149.7M | $94.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $7.2M | $7.7M | $6.8M | $5.2M | $5.1M | $4.5M | $3.4M | $4.2M | $2.3M | $1.1M | $701.0K | $654.0K | $1.0M | $917.0K | $947.0K | $642.0K | $550.0K | $360.0K | $310.0K | $197.0K | $95.0K |
| Stock Issued During Period Value Stock Options Exercised | $209.0K | $1.3M | $234.0K | $1.0M | $1.9M | $320.0K | $84.0K | $141.0K | $140.0K | $5.0K | $228.0K | $145.0K | $472.0K | $207.0K | $218.0K | ||||||
| Additional Paid In Capital | $793.3M | $785.9M | $560.3M | $508.4M | $502.2M | $494.9M | $396.9M | $393.4M | $389.0M | $235.5M | $235.0M | $234.6M | $232.5M | $184.5M | $181.9M | $179.3M | $178.4M | $167.2M | |||
| Depreciation | $74.0K | $79.0K | $67.0K | $39.0K | $25.0K | $24.0K | |||||||||||||||
| Vesting Of Restricted Stock And Stock Options | $66.0K | $68.0K | $73.0K | $74.0K | $74.0K | $73.0K | $69.0K | $80.0K | $64.0K | ||||||||||||
| Stock Issued During Period Value New Issues | $159.5M | $10.5M | $66.1M | ||||||||||||||||||
| Stock Issued During Period Value Conversion Of Convertible Securities | $149.7M | $94.9M |
Most recent annual filing with the SEC: March 3, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.